Fla. Stat. 465.188
Medicaid audits of pharmacies


(1)

Notwithstanding any other law, when an audit of the Medicaid-related records of a pharmacy licensed under chapter 465 is conducted, such audit must be conducted as provided in this section.The agency conducting the audit must give the pharmacist at least 1 week’s prior notice of the initial audit for each audit cycle.An audit must be conducted by a pharmacist licensed in this state.Any clerical or recordkeeping error, such as a typographical error, scrivener’s error, or computer error regarding a document or record required under the Medicaid program does not constitute a willful violation and is not subject to criminal penalties without proof of intent to commit fraud.A pharmacist may use the physician’s record or other order for drugs or medicinal supplies written or transmitted by any means of communication for purposes of validating the pharmacy record with respect to orders or refills of a legend or narcotic drug.A finding of an overpayment or underpayment must be based on the actual overpayment or underpayment and may not be a projection based on the number of patients served having a similar diagnosis or on the number of similar orders or refills for similar drugs.Each pharmacy shall be audited under the same standards and parameters.A pharmacist must be allowed at least 10 days in which to produce documentation to address any discrepancy found during an audit.The period covered by an audit may not exceed 1 calendar year.An audit may not be scheduled during the first 5 days of any month due to the high volume of prescriptions filled during that time.The audit report must be delivered to the pharmacist within 90 days after conclusion of the audit. A final audit report shall be delivered to the pharmacist within 6 months after receipt of the preliminary audit report or final appeal, as provided for in subsection (2), whichever is later.The audit criteria set forth in this section applies only to audits of claims submitted for payment subsequent to July 11, 2003. Notwithstanding any other provision in this section, the agency conducting the audit shall not use the accounting practice of extrapolation in calculating penalties for Medicaid audits.

(a)

The agency conducting the audit must give the pharmacist at least 1 week’s prior notice of the initial audit for each audit cycle.

(b)

An audit must be conducted by a pharmacist licensed in this state.

(c)

Any clerical or recordkeeping error, such as a typographical error, scrivener’s error, or computer error regarding a document or record required under the Medicaid program does not constitute a willful violation and is not subject to criminal penalties without proof of intent to commit fraud.

(d)

A pharmacist may use the physician’s record or other order for drugs or medicinal supplies written or transmitted by any means of communication for purposes of validating the pharmacy record with respect to orders or refills of a legend or narcotic drug.

(e)

A finding of an overpayment or underpayment must be based on the actual overpayment or underpayment and may not be a projection based on the number of patients served having a similar diagnosis or on the number of similar orders or refills for similar drugs.

(f)

Each pharmacy shall be audited under the same standards and parameters.

(g)

A pharmacist must be allowed at least 10 days in which to produce documentation to address any discrepancy found during an audit.

(h)

The period covered by an audit may not exceed 1 calendar year.

(i)

An audit may not be scheduled during the first 5 days of any month due to the high volume of prescriptions filled during that time.

(j)

The audit report must be delivered to the pharmacist within 90 days after conclusion of the audit. A final audit report shall be delivered to the pharmacist within 6 months after receipt of the preliminary audit report or final appeal, as provided for in subsection (2), whichever is later.

(k)

The audit criteria set forth in this section applies only to audits of claims submitted for payment subsequent to July 11, 2003. Notwithstanding any other provision in this section, the agency conducting the audit shall not use the accounting practice of extrapolation in calculating penalties for Medicaid audits.

(2)

The Agency for Health Care Administration shall establish a process under which a pharmacist may obtain a preliminary review of an audit report and may appeal an unfavorable audit report without the necessity of obtaining legal counsel. The preliminary review and appeal may be conducted by an ad hoc peer review panel, appointed by the agency, which consists of pharmacists who maintain an active practice. If, following the preliminary review, the agency or review panel finds that an unfavorable audit report is unsubstantiated, the agency shall dismiss the audit report without the necessity of any further proceedings.

(3)

This section does not apply to investigative audits conducted by the Medicaid Fraud Control Unit of the Department of Legal Affairs.

(4)

This section does not apply to any investigative audit conducted by the Agency for Health Care Administration when the agency has reliable evidence that the claim that is the subject of the audit involves fraud, willful misrepresentation, or abuse under the Medicaid program.

Source: Section 465.188 — Medicaid audits of pharmacies, https://www.­flsenate.­gov/Laws/Statutes/2024/0465.­188 (accessed Aug. 7, 2025).

465.001
Short Title
465.002
Legislative findings
465.003
Definitions
465.004
Board of Pharmacy
465.005
Authority to make rules
465.006
Disposition of fees
465.007
Licensure by examination
465.008
Renewal of license
465.009
Continuing professional pharmaceutical education
465.012
Reactivation of license
465.013
Registration of pharmacy interns
465.014
Pharmacy technician
465.015
Violations and penalties
465.016
Disciplinary actions
465.017
Authority to inspect
465.018
Community pharmacies
465.019
Institutional pharmacies
465.022
Pharmacies
465.023
Pharmacy permittee
465.024
Promoting sale of certain drugs prohibited
465.025
Substitution of drugs
465.026
Filling of certain prescriptions
465.027
Exceptions
465.035
Dispensing of medicinal drugs pursuant to facsimile of prescription
465.0075
Licensure by endorsement
465.0125
Consultant pharmacist license
465.0126
Nuclear pharmacist license
465.0155
Standards of practice
465.0156
Registration of nonresident pharmacies
465.0157
International export pharmacy permit
465.0158
Nonresident sterile compounding permit
465.0161
Distribution of medicinal drugs without a permit
465.0181
Community pharmacy permit required to dispense Schedule II or Schedule III controlled substances
465.185
Rebates prohibited
465.186
Pharmacist’s order for medicinal drugs
465.187
Sale of medicinal drugs
465.188
Medicaid audits of pharmacies
465.189
Administration of vaccines and epinephrine autoinjection
465.0193
Nuclear pharmacy permits
465.0196
Special pharmacy permits
465.0197
Internet pharmacy permits
465.0235
Automated pharmacy systems used by long-term care facilities, hospices, or state correctional institutions, or for outpatient dispensing
465.0244
Information disclosure
465.0251
Generic drugs
465.0252
Substitution of interchangeable biosimilar products
465.0255
Expiration date of medicinal drugs
465.0265
Centralized prescription filling
465.0266
Common database
465.0275
Emergency prescription refill
465.0276
Dispensing practitioner
465.1861
Ordering and dispensing HIV infection prevention drugs
465.1865
Collaborative pharmacy practice for chronic health conditions
465.1893
Administration of antipsychotic medication by injection
465.1895
Testing or screening for and treatment of minor, nonchronic health conditions
465.1901
Practice of orthotics and pedorthics
465.1902
Prescription Drug Donation Repository Program

Current through Fall 2025

§ 465.188. Medicaid audits of pharmacies's source at flsenate​.gov